CD4 and neoplasm: In most tumors, SPA17was positively associated with the infiltration of MDSC, CD4+ T cells, progenitors of lymphoid, and CD8+ T cells, suggesting that SPA17 was likely to affect tumor development and prognosis by impacting the tumor microenvironment.